| Item Type | Name |
|
Concept
|
Levodopa
|
|
Academic Article
|
Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.
|
|
Academic Article
|
The first miracle in neurodegenerative disease: the discovery of oral levodopa.
|
|
Academic Article
|
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics.
|
|
Academic Article
|
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies.
|
|
Academic Article
|
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).
|
|
Academic Article
|
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
|
|
Academic Article
|
Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
|
|
Academic Article
|
Hallucinations in Parkinson disease in the prelevodopa era.
|
|
Academic Article
|
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
|
|
Academic Article
|
Safety of rasagiline in elderly patients with Parkinson disease.
|
|
Academic Article
|
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
|
|
Academic Article
|
Levodopa-induced dyskinesias.
|
|
Academic Article
|
Hallucinations in Parkinson disease.
|
|
Academic Article
|
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
|
|
Academic Article
|
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
|
|
Academic Article
|
Recent advances in the biochemical pharmacology of extrapyramidal movement disorders.
|
|
Academic Article
|
Chronic agonist-induced hypersensitivity and on-off hyperkinesis.
|
|
Academic Article
|
Clonazepam and dopamine-related stereotyped behavior.
|
|
Academic Article
|
Levodopa-induced dopamine receptor hypersensitivity.
|
|
Academic Article
|
Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea.
|
|
Academic Article
|
Levodopa-induced myoclonus.
|
|
Academic Article
|
Core assessment program for intracerebral transplantations (CAPIT).
|
|
Academic Article
|
Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures.
|
|
Academic Article
|
New approaches in the treatment of the dystonias.
|
|
Academic Article
|
United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up.
|
|
Academic Article
|
Hypersexuality with antiparkinsonian therapy.
|
|
Academic Article
|
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.
|
|
Academic Article
|
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.
|
|
Academic Article
|
The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients.
|
|
Academic Article
|
Drug-induced myoclonus.
|
|
Academic Article
|
Progression of Parkinson's disease without levodopa.
|
|
Academic Article
|
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet).
|
|
Academic Article
|
Controlled-release Sinemet.
|
|
Academic Article
|
Pergolide mesylate: four years experience in Parkinson's disease.
|
|
Academic Article
|
Autonomic dysfunction in Parkinson's disease.
|
|
Academic Article
|
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
|
|
Academic Article
|
Animal models of tardive dyskinesia: their use in the search for new treatment methods.
|
|
Academic Article
|
Skin rash associated with Sinemet 25/100.
|
|
Academic Article
|
Sinemet skin rash.
|
|
Academic Article
|
A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease.
|
|
Academic Article
|
Presymptomatic and early detection in Huntington's disease.
|
|
Academic Article
|
The pharmacology of olivopontocerebellar atrophy.
|
|
Academic Article
|
Drug holiday in the management of Parkinson disease.
|
|
Academic Article
|
Levodopa-free periods ("drug holidays") in the management of parkinsonism.
|
|
Academic Article
|
Pergolide mesylate and idiopathic Parkinson disease.
|
|
Academic Article
|
Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig.
|
|
Academic Article
|
The effect of bromocriptine (BCT) on the on-off phenomenon.
|
|
Academic Article
|
Weekly drug holiday in Parkinson disease.
|
|
Academic Article
|
A pure parkinsonian syndrome following acute carbon monoxide intoxication.
|
|
Academic Article
|
Complications of chronic levodopa therapy: long-term efficacy of drug holiday.
|
|
Academic Article
|
The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig.
|
|
Academic Article
|
Drug-induced asterixis in Parkinson disease.
|
|
Academic Article
|
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
|
|
Academic Article
|
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.
|
|
Academic Article
|
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise.
|
|
Academic Article
|
Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
|
|
Academic Article
|
Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use.
|
|
Academic Article
|
Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation.
|
|
Academic Article
|
New strategies with dopaminergic drugs: modified formulations of levodopa and novel agonists.
|
|
Academic Article
|
The stability of carbidopa in solution.
|
|
Academic Article
|
Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations.
|
|
Academic Article
|
Highlights of the North American and European experiences.
|
|
Academic Article
|
Influence of COMT inhibition on levodopa pharmacology and therapy.
|
|
Academic Article
|
Early dopaminergic drug-induced hallucinations in parkinsonian patients.
|
|
Academic Article
|
Poor visual discrimination and visual hallucinations in Parkinson's disease.
|
|
Academic Article
|
Parkinson's disease.
|
|
Academic Article
|
Rating scales for dyskinesias in Parkinson's disease.
|
|
Academic Article
|
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
|
|
Academic Article
|
Differential progression of motor impairment in levodopa-treated Parkinson's disease.
|
|
Academic Article
|
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
|
|
Academic Article
|
Early morning off-medication dyskinesias, dystonia, and choreic subtypes.
|
|
Academic Article
|
Complete genomic screen in Parkinson disease: evidence for multiple genes.
|
|
Academic Article
|
Prospective longitudinal assessment of hallucinations in Parkinson's disease.
|
|
Academic Article
|
Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
|
|
Academic Article
|
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling.
|
|
Academic Article
|
Cross-Cultural Differences in Patient Perceptions of Dyskinesia in Parkinson's Disease.
|